Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-12-16

Clinical Trial Update: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of dapagliflozin for chronic kidney disease in adolescents and young adults is currently recruiting, sponsored by University Hospital Goe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University Hospital Goettingen | Conditions: Chronic Kidney Failure in Children and Young Adults | Phase 3 | Status: RECRUITING